278 related articles for article (PubMed ID: 29895126)
1. Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.
Kővári B; Kocsis L; Varga E; Cserni G
Pol J Pathol; 2018; 69(1):48-52. PubMed ID: 29895126
[TBL] [Abstract][Full Text] [Related]
2. The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.
Kővári B; Vranic S; Marchio C; Sapino A; Cserni G
Hum Pathol; 2017 Jun; 64():164-170. PubMed ID: 28438614
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
4. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis.
Mahalingam M; Srivastava A; Hoang MP
Am J Dermatopathol; 2010 Dec; 32(8):774-9. PubMed ID: 20700038
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
Mazoujian G
Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
[TBL] [Abstract][Full Text] [Related]
6. Her-2 expression in cutaneous eccrine and apocrine neoplasms.
Hiatt KM; Pillow JL; Smoller BR
Mod Pathol; 2004 Jan; 17(1):28-32. PubMed ID: 14631375
[TBL] [Abstract][Full Text] [Related]
7. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.
Wood A; Houghton SL; Biswas A
Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
9. Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors.
Saga K
J Investig Dermatol Symp Proc; 2001 Nov; 6(1):49-53. PubMed ID: 11764285
[TBL] [Abstract][Full Text] [Related]
10. Unusual apocrine carcinoma with neuroendocrine differentiation: a cutaneous neoplasm may be analogous to neuroendocrine carcinoma with apocrine differentiation of breast.
Li Y; Chen LL; Li B; Tian XY; Li Z
Diagn Pathol; 2015 Jun; 10():64. PubMed ID: 26055980
[TBL] [Abstract][Full Text] [Related]
11. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
Wong TY; Suster S; Cheek RF; Mihm MC
Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
[TBL] [Abstract][Full Text] [Related]
12. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.
Kővári B; Rusz O; Schally AV; Kahán Z; Cserni G
APMIS; 2014 Sep; 122(9):824-31. PubMed ID: 24479854
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of GCDFP-15 expression in human fetal and adult normal tissues.
Viacava P; Naccarato AG; Bevilacqua G
Virchows Arch; 1998 Mar; 432(3):255-60. PubMed ID: 9532005
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous apocrine carcinoma versus metastasis, a plea to the dermatopathology community.
Fernandez-Flores A
Am J Dermatopathol; 2010 Dec; 32(8):853-4. PubMed ID: 20431390
[No Abstract] [Full Text] [Related]
15. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
Mazoujian G; Margolis R
Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous apocrine mixed tumor: derived from the apocrine duct of the folliculo-sebaceous-apocrine unit?
Gianotti R; Coggi A; Alessi E
Am J Dermatopathol; 1998 Jun; 20(3):323-5. PubMed ID: 9650712
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
18. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors.
Tsubura A; Senzaki H; Sasaki M; Hilgers J; Morii S
J Cutan Pathol; 1992 Feb; 19(1):73-9. PubMed ID: 1556271
[TBL] [Abstract][Full Text] [Related]
20. Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.
Obaidat NA; Alsaad KO; Ghazarian D
J Clin Pathol; 2007 Feb; 60(2):145-59. PubMed ID: 16882695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
